| Autor: |
Ray, Lipika, Karthik, R., Srivastava, Vikas, Singh, Sheelendra Pratap, Pant, A. B., Goyal, Neena, Gupta, Kailash C. |
| Zdroj: |
Drug Delivery and Translational Research; 20240101, Issue: Preprints p1-13, 13p |
| Abstrakt: |
Amphotericin B (AmB) exhibits potential antileishmanial activity, with only a little rate of recurrence. However, low bioavailability and severe nephrotoxicity are among the major shortcomings of AmB-based therapy. Various AmB nanoformulations have been developed, which to an extent, have reduced its toxicity and increased the drug efficacy. To further reduce the nonspecific tissue distribution and the cost of the treatment, the current AmB-based formulations require additional improvements. Combination of natural bioenhancers with AmB is expected to further increase its bioavailability. Therefore, we developed a nanoformulation of AmB and piperine (Pip), a plant alkaloid, known to enhance the bioavailability of various drugs, by entrapping them in guar gum, a macrophage targeting polymer. Owing to the ease of oral delivery, these nanoparticles (NPs) were coated with eudragit to make them suitable for oral administration. The formulated eudragit-coated AmB and Pip-loaded NPs (Eu-HDGG-AmB-Pip-NPs) exhibited controlled release of the loaded therapeutic agents and protected the drug from acidic pH. These NPs exhibited effective suppression of growth of both promastigotes and amastigotes of Leishmania donovaniparasite under in vitro. In vivo evaluation of these NPs for therapeutic efficacy in golden hamster-L. donovanimodel demonstrated enhanced drug bioavailability, non-nephrotoxic nature, and potential antileishmanial activity with up to 96% inhibition of the parasite. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink